Delivery device for balloon expandable endoprosthesis
By designing stent graft and catheter assembly in the endoprosthesis, the expansion rate of the balloon is controlled, and the problem of longitudinal compression of the endoprosthesis during the deployment process is solved, and efficient deployment configuration and compressed configuration length are achieved. Improves the flexibility and strength of the equipment.
Patent Information
- Application Number
- CN202411174090.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2015-11-24
- Filing Date
- 2015-11-25
- Publication Date
- 2024-12-03
AI Technical Summary
During the transition from the unexpanded state to the unexpanded state of the endoprosthesis, the rapid expansion of the balloon leads to a longitudinal force, resulting in a reduction in the longitudinal length of the endoprosthesis. It is difficult for the prior art to effectively reduce this compression effect.
A medical device is designed, including a stent graft and catheter assembly. The middle part of the stent graft controls the expansion of the balloon by applying resistance, and the cover further reduces the expansion rate of the balloon at the free end, ensuring that the endoprosthesis is in Reduces longitudinal compression when expanded.
Effectively reduce the longitudinal compression of the endoprosthesis during the deployment process, ensure that the expansion length reaches or exceeds 85% of the undistributed length, and maintain sufficient flexibility and radial strength in the deployment state, and be able to withstand bending less than about 8mm Radius without kink.
Smart Images

Figure CN119055404A_ABST
Abstract
Description
[0001] This application is a divisional application of the invention patent application with Chinese application number 201911264463.8 and title “DELIVERY DEVICE FOR BALLOON-EXPANSIBLE ENDOPESSION” (the invention patent application with Chinese application number 201911264463.8 is a divisional application of the invention patent application with application number 201580051125.X and title “DELIVERY DEVICE FOR BALLOON-EXPANSIBLE ENDOPESSION” which has entered the Chinese national phase). Technical Field
[0002] The present disclosure relates generally to endoprostheses for treating vasculature, and more particularly to balloon-expandable endoprostheses. Background Art
[0003] Endoprostheses are valuable tools for improving and saving lives. In many cases, endoprostheses are inserted into the vascular system in an "undeployed" state and must be expanded to an "expanded" state. In order for the endoprosthesis to transition between these two states, a balloon can be located within the endoprosthesis in its undeployed state and inflated, the expansion of the balloon pushing the endoprosthesis into its expanded state. However, in many cases, the balloon extends beyond the longitudinal length of the endoprosthesis. Therefore, those portions of the balloon that are not constrained by the endoprosthesis expand more rapidly than those portions of the balloon within the endoprosthesis, causing the balloon to exert a longitudinal force on the endoprosthesis that causes the longitudinal length of the endoprosthesis to decrease. In addition to other features and benefits discussed in more detail below, aspects of the present disclosure reduce this effect so as to form an improved endoprosthesis. Summary of the invention
[0004] In one embodiment, a medical device includes a stent graft defining a first free end, a second free end, and a middle portion between the first and second free ends, the stent graft having an undeployed state and an expanded state, the undeployed state having an undeployed diameter and an undeployed longitudinal length between the first free end and the second free end, and the expanded state having an expanded diameter and an expanded longitudinal length between the first free end and the second free end. The stent graft includes a stent portion and a graft portion. The medical device also includes a catheter assembly to which the stent graft is assembled in the undeployed state. The catheter assembly includes a balloon and a covering concentrically surrounding the balloon. The middle portion of the stent graft applies a resistance to the expansion of the balloon at the middle portion of the stent graft, and the covering also applies a resistance to the expansion of the balloon to reduce the difference in the expansion rate of the balloon at the free ends of the stent graft relative to the expansion rate of the balloon at the middle portion of the stent graft, so as to reduce the longitudinal compression of the stent graft when the balloon expands the stent graft from its undeployed state to its expanded state.
[0005] In one variation, the deployed length of the stent graft is at least 85% of the undeployed length of the stent graft.
[0006] In one variation, the covering includes a reinforcement portion configured to resist inflation of a corresponding shoulder portion of the balloon to reduce longitudinal compression of the stent graft when the balloon expands the stent graft from its undeployed state to its deployed state.
[0007] In one variation, the stent portion of the stent graft comprises a plurality of annular stent elements that are individual components connected by the graft portion of the stent graft.
[0008] In one variation, the graft portion is configured to store a longitudinal length of the stent graft when the stent graft is in an undeployed state.
[0009] In one variation, the graft portion of the stent graft is formed from ePTFE.
[0010] In another embodiment, a medical device includes a stent graft defining a first free end, a second free end, and a middle portion between the first and second free ends, the stent graft having an undeployed state and an deployed state, the undeployed state having an undeployed longitudinal length between the first free end and the second free end, and the deployed state having an expanded longitudinal length between the first free end and the second free end. The stent graft includes a stent portion and a graft portion. A catheter assembly on which the stent graft in the undeployed state is assembled includes a balloon and a covering concentrically surrounding the balloon, the middle portion of the stent graft applying a resistance to expansion of the balloon at the middle portion of the stent graft, and the covering also applying a resistance to expansion of the balloon, such that the deployed length of the stent graft is at least 85% of the undeployed length of the stent graft.
[0011] In one variation, the graft portion of the stent graft is formed from ePTFE.
[0012] In one embodiment, a medical device includes a stent graft comprising an inner ePTFE graft element, an outer ePTFE graft element, and a plurality of annular stent elements positioned between the inner and outer ePTFE graft elements, the stent graft having an undeployed state and a deployed state, the undeployed state having an undeployed diameter, the deployed state having an deployed diameter greater than the undeployed diameter; and a catheter assembly including a balloon concentrically surrounded by a covering, the covering including a reinforcement portion configured to resist inflation of a corresponding shoulder portion of the balloon so as to reduce longitudinal compression of the stent graft when the balloon expands the stent graft from its undeployed state to its deployed state.
[0013] In one variation, the reinforced portion of the covering maintains an expanded profile of the balloon that reduces the amount of radial expansion of a shoulder portion of the balloon relative to a mid-portion of the balloon when the balloon is inflated.
[0014] In one variation, the plurality of annular stent elements are configured to store a longitudinal length when the stent graft is in an undeployed state.
[0015] In one variation, the stent graft has an undeployed length in the undeployed state and a deployed length in the deployed state, wherein the deployed length is between 85% and 99% of the undeployed length.
[0016] In one variation, the deployed diameter is about 10 mm, and wherein the stent graft is sufficiently flexible to undergo a bend radius of less than about 8 mm without kinking (bending) when in the deployed state.
[0017] In one variation, the deployed diameter is about 10 mm, and wherein the stent graft has a radial strength of between about 11 psi (pounds per square inch) and about 12 psi (pounds per square inch) when in the deployed state.
[0018] In one variation, at least one annular stent element is spaced apart from an adjacent annular stent element by between about 0.5 mm and about 2.0 mm when the stent graft is in the expanded state.
[0019] In one variation, the at least one annular stent element is spaced apart from an adjacent annular stent element by between about 0.0 mm and about 0.2 mm when the stent graft is in an undeployed state.
[0020] In one variation, the plurality of annular stent elements comprises an interconnected wire framework.
[0021] In one variation, when the stent graft is in the expanded state, the interior angle of one of the interconnected wire frames is about 90 degrees.
[0022] In one variation, the plurality of annular stent elements comprises a single row of interconnected diamond-shaped wire frames.
[0023] In one variation, the plurality of annular support elements comprises stainless steel.
[0024] In one variation, an apex of a first annular stent element is out of phase with an adjacent apex of a second annular stent element along the longitudinal axis.
[0025] In another embodiment, a medical device includes: a stent graft having an undeployed state and a deployed state, the undeployed state having an undeployed diameter and an undeployed length, the deployed state having a deployed diameter and a deployed length, the stent graft comprising an inner graft element, an outer graft element, and a plurality of annular stent elements positioned between and attached to the inner graft element and the outer graft element; and a catheter assembly including: a balloon having a (circular) conical end; a covering concentrically surrounding the balloon, the covering having a middle portion and a reinforcement portion concentrically surrounding the (circular) conical end of the balloon, the reinforcement portion of the covering having a higher density than the density of the middle portion of the covering so as to maintain an expanded profile that reduces longitudinal compression of the stent graft.
[0026] In one variation, when the stent graft is in its undeployed state, the spacing of at least some of the plurality of annular stent elements stores a longitudinal length restored by the stent graft in its deployed state.
[0027] In one variation, the deployed length exhibits less than 1% shortening compared to the undeployed length.
[0028] In one variation, the stent graft is compressed onto the covering to resist movement of the stent graft relative to the balloon prior to deployment.
[0029] In one variant, the reinforced portion of the cover has a radial strength greater than the radial strength of the middle portion.
[0030] In one variation, the outer graft element includes an outer surface comprising ePTFE in contact with an inner surface of the covering, and the inner surface of the covering includes ePTFE.
[0031] In one variation, the balloon comprises nylon.
[0032] In one variation, the luminal surface of the inner graft element includes an anti-thrombotic coating.
[0033] In one variation, the reinforced portion of the covering resists expansion of the (conical) conical end of the balloon during inflation of the balloon.
[0034] In one variation, the reinforced portion of the covering comprises an axially compressed portion of the covering.
[0035] In one variation, the reinforced portion of the covering comprises a pleated portion of the covering.
[0036] In one variation, the pleats in the pleated portion of the covering correspond to the pleats in the pleated portion of the balloon.
[0037] In another embodiment, a method of making a stent graft includes: placing a plurality of annular stent elements along a longitudinal axis and between an inner graft element and an outer graft element; compressing the plurality of annular stent elements, the inner graft element, and the outer graft element into a compressed configuration; and moving at least two of the plurality of annular stent elements closer together to store longitudinal length such that when the stent graft is expanded to an expanded configuration (deployed configuration), the stored longitudinal length is restored.
[0038] In another embodiment, a method of preparing a deployment system includes assembling a stent graft to a deployment device, the stent graft having a first free end, a second free end, a middle portion between the first and second free ends, and a first diameter in an undeployed state, and the deployment device having a balloon and a covering surrounding the balloon, the stent graft being assembled to the deployment device such that the stent graft surrounds the covering and the balloon, the middle portion of the stent graft exerts a resistance to expansion of the balloon, and the covering also exerts a resistance to expansion of the balloon to reduce a difference in an expansion rate of the balloon at the middle portion of the stent graft relative to an expansion rate of the balloon at the first and second free ends of the stent graft to reduce longitudinal compression of the stent graft when the balloon expands to transition the stent graft from an undeployed state (undeployed state) to an expanded state (deployed state).
[0039] In one variation, moving the at least two of the plurality of annular stent elements closer together includes moving the at least two of the plurality of annular stent elements from a separation distance between about 0.5 mm and about 2.0 mm to a separation distance between about 0.0 mm and about 0.2 mm.
[0040] In one variation, the method further comprises placing a covering on the balloon, the covering having at least one reinforced portion overlying a shoulder of the balloon, the at least one reinforced portion providing increased resistance to inflation relative to a middle portion of the covering; and placing a stent graft on the middle portion of the covering such that the reinforced portion of the covering reduces longitudinal compressive forces exerted on the stent graft during inflation of the balloon.
[0041] In one variation, the stent graft exhibits a longitudinal efficiency of greater than 99% when the stent graft is expanded from the compressed configuration to the expanded configuration.
[0042] In another embodiment, a method for treating a patient includes: inserting a stent graft into a vessel of the patient, the stent graft having a first length and a first diameter, the stent graft surrounding a middle portion of a covering, the middle portion of the covering concentrically surrounding a balloon, the covering and the balloon each having a length greater than the first length of the stent graft, such that at least one shoulder of the balloon and a corresponding portion of the covering are outside the stent graft, the corresponding portion of the covering being reinforced to provide a greater resistance to inflation of the shoulder of the balloon than the middle portion of the covering provides to the middle portion of the balloon; and applying pressure to the balloon to expand the stent graft to a second diameter greater than the first diameter and to expand the stent graft to a second length, the reinforced portion of the covering limiting inflation of the shoulder of the balloon to limit longitudinal compressive forces on the stent graft.
[0043] In one variation, the second length of the stent graft is at least 85% of the first length of the stent graft.
[0044] In one variation, the reinforced portion of the covering comprises a constricted portion of the covering.
[0045] In one variation, the reinforced portion of the covering comprises a pleated portion of the covering.
[0046] In one variation, the pleats in the pleated portion of the covering correspond to the pleats in the pleated portion of the balloon.
[0047] In another embodiment, a method for treating a patient includes inserting a stent graft into a vessel of the patient, the stent graft having a first length and a first diameter, the stent graft surrounding a covering, the covering surrounding a balloon, the stent graft including a plurality of stent elements positioned to store a longitudinal length; and applying pressure to the balloon to expand the stent graft to a second diameter greater than the first diameter and to a second length, wherein expanding the stent graft restores the stored longitudinal length.
[0048] In one variation, the second length of the stent graft is between 85% and 99% of the first length of the stent graft.
[0049] In one variation, the second length of the stent graft is at least 85% of the first length of the stent graft.
[0050] In one variation, the second length of the stent graft is at least 99% of the first length of the stent graft.
[0051] In another embodiment, a method for treating a patient includes inserting a stent graft into a vessel of the patient, the stent graft having a first free end, a second free end, a midsection between the first and second free ends, and a first diameter, the stent graft surrounding a covering, the covering surrounding a balloon, the stent graft comprising a plurality of stent elements; and applying pressure to the balloon to expand the stent graft from an undeployed state to a deployed state, the deployed state having a second diameter greater than the first diameter, the midsection of the stent graft resisting expansion of the balloon, and the covering also resisting expansion of the balloon to reduce a difference in an expansion rate of the balloon at the midsection of the stent graft relative to an expansion rate of the balloon at the first and second free ends of the stent graft to reduce longitudinal compression of the stent graft when the balloon expands the stent graft from the undeployed state to the deployed state.
[0052] In one variation, the second length of the stent graft is between 85% and 99% of the first length of the stent graft.
[0053] In one variation, the stent graft defines a first length in an undeployed state and a second length in an deployed state, the second length being at least 85% of the first length.
[0054] In one variation, the stent graft defines a first length in an undeployed state and a second length in an deployed state, the second length being at least 99% of the first length. BRIEF DESCRIPTION OF THE DRAWINGS
[0055] Features and advantages of the present disclosure will become more apparent from the detailed description set forth below in conjunction with the accompanying drawings, in which:
[0056] Figure 1A and Figure 1B shows a side view of an endoprosthesis according to an embodiment of the present disclosure;
[0057] Figure 2A and Figure 2B shows a side view and partial cross-sectional view of an endoprosthesis delivery system according to an embodiment of the present disclosure;
[0058] Figure 3 shows a perspective view of a medical device delivery system according to an embodiment of the present disclosure;
[0059] Figure 4A and Figure 4B sectional views of an undeployed balloon and covering and a deployed balloon, covering, and endoprosthesis, respectively, according to an embodiment of the present disclosure; and
[0060] Figures 5A-5F Shown are side views of an endoprosthesis delivery system according to an embodiment of the present disclosure at various stages of deployment. DETAILED DESCRIPTION
[0061] It will be readily appreciated by those skilled in the art that various aspects of the present disclosure may be implemented by many methods and devices configured to perform the intended functions. In other words, other methods and devices may be incorporated herein to perform the intended functions. It should also be noted that the drawings cited herein are not necessarily drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in this regard, the drawings should not be construed as limiting. Finally, although the present disclosure may be described in conjunction with various principles and doctrines, the present disclosure should not be bound by theory.
[0062] Throughout the specification and claims, the terms "endoprosthesis device", "endoprosthesis", "vascular device", etc. may refer to any medical device that can be implanted and / or deployed in a body lumen. In various embodiments, the endoprosthesis may include stents, stent grafts, grafts, filters, occluders, balloons, leads, as well as energy transmission devices, deployable patches, indwelling catheters, etc.
[0063] Furthermore, throughout this specification and claims, the delivery systems described herein may generally include an endoprosthesis constrained by a "covering member" or "sheath." In various embodiments, the covering member or sheath may include a sheet of material (sheet of material) that fits around the endoprosthesis. As used throughout the specification and claims, the term "elongated member" may refer to a shaft-like structure, such as a catheter, a guidewire, an introducer sheath, etc. In various embodiments, the endoprosthesis may be mounted or loaded onto a catheter (also referred to herein as an inner shaft) and fit within an introducer sheath (also referred to herein as an outer shaft) with a constrained diameter.
[0064] In addition, the term "distal" refers to a relative position further away from the position in the body where the medical device is introduced. Similarly, the term "distal" refers to a direction away from the position in the body where the medical device is introduced.
[0065] The term "proximal" refers to a relative position that is closer to the location in the body where the medical device is introduced. Similarly, the term "proximally" refers to a direction toward the location in the body where the medical device is introduced.
[0066] Still with respect to the terms proximal and distal, the present disclosure should not be construed narrowly with respect to these terms. Rather, the devices and methods described herein may be altered and / or adjusted relative to the anatomy of a patient.
[0067] As used herein, the term "constraint" may mean (i) limiting the expansion of the diameter of an expandable implant, such expansion occurring through self-expansion or by device-assisted expansion; or (ii) covering or surrounding but not otherwise constraining the expandable implant (e.g., for storage or biocompatibility reasons and / or to provide protection to the expandable implant and / or the vasculature).
[0068] As used herein, the term "vascular" refers to any lumen or tubular structure within the body to which these constructs may be applied. This includes, but is not limited to, blood vessels, conduits such as arteriovenous malformations, aneurysms or other vascular defects, the lymphatic system, the esophagus, intestinal anatomy, sinus cavities, the genitourinary system, or other such systems or anatomical features. Embodiments of the present invention are also suitable for treating malignant diseases (e.g., cancer) within or associated with a vessel.
[0069] First refer to Figure 1A and Figure 1B , an endoprosthesis 100 is shown. The endoprosthesis 100 may include, for example, an expandable stent graft. In various embodiments, the endoprosthesis 100 includes a balloon expandable stent graft. Although the endoprosthesis 100 will be described herein as a balloon expandable stent graft, the endoprosthesis 100 may include other implantable, expandable medical devices, including self-expanding stent grafts.
[0070] In various embodiments, stent graft 100 includes stent component 102. For example, stent component 102 can include one or more annular stent elements 104. As will be discussed in more detail, annular stent elements 104 can be positioned adjacent to each other along a longitudinal axis 192 of stent graft 100. In various embodiments, annular stent elements 104 are evenly spaced from each other (i.e., evenly distributed along the longitudinal axis). In other embodiments, one or more annular stent elements 104 can be spaced from each other at different spacings along longitudinal axis 192 (i.e., unevenly distributed along the longitudinal axis). Any arrangement of annular stent elements 104 is within the scope of the present disclosure.
[0071] The annular stent element 104 may include, for example, interconnected wire frames 106 arranged in an annular pattern. For example, the annular stent element 104 may include a single row of interconnected wire frames 106. One or more points 118 of the wire frames 106 may contact and connect to points 118 of adjacent wire frames 106. In various embodiments, the annular stent element 104 may include a plurality of individual wire frames 106 that are formed independently of one another and connected to one another at one or more points 118. In other embodiments, the wire frames 106 are formed together as a single interconnected stent element 104.
[0072] In various embodiments, the annular stent elements 104 may differ in stiffness from one another. For example, one or more annular stent elements 104 having increased stiffness may be located at the distal and / or proximal ends of the stent graft 100. Additionally, one or more annular stent elements 104 having decreased stiffness may be located away from the distal and / or proximal ends of the stent graft 100. Any combination of annular stent elements 104 including multiple elements having different stiffnesses from one another is within the scope of the present disclosure.
[0073] The wire frame 106 may include a polygon, such as a parallelogram. In various embodiments, the wire frame 106 includes a rhombus. In other embodiments, the wire frame 106 may include a square or rectangular shape. Any shape of the wire frame 106 including a shape that is not a polygon (e.g., an oval or rounded shape) or including an undulating or curved shape is within the scope of the present disclosure.
[0074] In various embodiments, the wire frame 106 comprises a metallic material. For example, the wire frame 106 may comprise steel, such as stainless steel or other alloys. In other embodiments, the wire frame 106 may comprise a shape memory alloy, such as nitinol. In still other embodiments, the wire frame 106 comprises a non-metallic material, such as a polymer material. In addition, the material of the wire frame 106 may be permanent (i.e., non-bioresorbable) or bioresorbable. Any material of the wire frame 106 having sufficient strength is within the scope of the present disclosure.
[0075] For example, the annular support element 104 may be cut, for example, from a single metal tube. In various embodiments, the annular support element 104 is laser cut from a stainless steel tube. However, any manner of forming the annular support element 104 and / or the wire frame 106 is within the scope of the present disclosure.
[0076] The endoprosthesis 100 may also include a graft member 114. The graft member 114 may, for example, provide a lumen through which blood may flow from one end to the other. In addition, as will be discussed in greater detail, the graft member 114 may include multiple layers or elements secured together to form a single graft member 114.
[0077] The graft component 114 may include, for example, an inner graft element 108. In various embodiments, the stent component 102 is concentrically positioned around the inner graft element 108. For example, the inner graft element 108 may include a layer of polymeric material having a luminal surface 110 that contacts blood flow within a vessel. The stent component 102 may surround, contact, and provide support to the inner graft element 108.
[0078] In various embodiments, the inner graft element 108 comprises a polymer film that can provide a bypass route to avoid vascular injuries or malformations such as aneurysms. The inner graft element 108 may include, for example, expanded polytetrafluoroethylene (ePTFE), polyester, polyurethane, fluoropolymers such as perfluoroelastomer, polytetrafluoroethylene, silicone, urethane, ultra-high molecular weight polyethylene, aramid fibers, and combinations thereof. Other embodiments of graft component materials may include high-strength polymer fibers, such as ultra-high molecular weight polyethylene fibers (e.g., Dyneema etc.) or aramid fibers (e.g. Any graft component capable of providing a lumen for fluid flow within a patient's body is within the scope of the present disclosure.
[0079] The inner graft element 108 can include, for example, one or more layers of a polymer material. In various embodiments, the inner graft element 108 includes a polymer material that is continuously wrapped around a substrate or mandrel to form a generally tubular member. For example, the inner graft element 108 can be constructed with a polymer material that is circumferentially, helically, or axially oriented. As used herein, "orientation" generally refers to a directional property of a component or material (e.g., a polymer material), often with reference to a longitudinal axis 192. Orientation can also be used to refer to the directional property of certain features, for example, the orientation of the strength of a material.
[0080] In the embodiments discussed above, the polymeric material may be wrapped generally perpendicular to the longitudinal axis of the mandrel or substrate, i.e., wrapped circumferentially. In other embodiments, the material may be wrapped at an angle between greater than 0 degrees and less than 90 degrees relative to the longitudinal axis of the mandrel or substrate, i.e., wrapped helically. In still other embodiments, the polymeric material may be wrapped generally parallel to the longitudinal axis of the mandrel or substrate, i.e., wrapped axially (or longitudinally).
[0081] In various embodiments, inner graft element 108 can include a coating on luminal surface 110. For example, a therapeutic agent such as an anti-thrombotic coating can be applied to luminal surface 110. In various embodiments, a heparin coating is applied to luminal surface 110.
[0082] Graft component 114 can also include, for example, outer graft element 112. In various embodiments, outer graft element 112 concentrically surrounds at least a portion of stent component 102. For example, outer graft element 112 can concentrically surround stent component 102 and inner graft element 108, thereby substantially sandwiching annular stent element 104 of stent component 102 between the two graft elements 108 and 112.
[0083] Similar to the inner graft element 108, the outer graft element 112 may include, for example, expanded polytetrafluoroethylene (ePTFE), polyester, polyurethane, fluoropolymers such as perfluoroelastomer, polytetrafluoroethylene, silicone, urethane, ultra high molecular weight polyethylene, aramid fibers, and combinations thereof. The outer graft element 112 may include high strength polymer fibers, for example, ultra high molecular weight polyethylene fibers (e.g., Dyneema etc.) or aramid fibers (e.g. In addition, outer graft element 112 can include one or more layers of polymeric material and can be a tube or wrapped element as described in conjunction with inner graft element 108. In various embodiments, inner graft element 108 and outer graft element 112 include the same polymeric material. In other embodiments, inner graft element 108 and outer graft element 112 include different polymeric materials.
[0084] In such embodiments, the inner graft elements 108 and the outer graft elements 112 may orient and maintain the position of each of the plurality of annular stent elements 104. For example, each annular stent element 104 of the stent component 102 may be positioned at a desired location along the inner graft elements 108 and then surrounded by the outer graft elements 112. In various embodiments, after the annular stent elements 104 are properly positioned along the inner graft elements 108, the inner graft elements 108 and the outer graft elements 112 are bonded together. For example, heat may be applied to bond the inner graft elements 108 and the outer graft elements 112 together, thereby maintaining the position of the annular stent elements 104 relative to the graft components 114.
[0085] In various embodiments, the annular stent elements 104 are spaced a desired distance from each other. For example, each of the annular stent elements 104 can be positioned between about 0 mm (i.e., one annular stent element 104 abuts another) and about 4 mm away from each other. In various embodiments, each of the annular stent elements 104 can be between about 1.0 mm and about 2.0 mm away from each other, and in particular embodiments, between about 1.1 mm and 1.5 mm away from each other. Although described with reference to specific embodiments, the annular stent elements 104 of the stent component 102 can be spaced any distance apart, including multiple different spacings within the same stent component 102.
[0086] Furthermore, in embodiments where stent component 102 includes spaced-apart annular stent elements 104, stent graft 100 may include one or more endo-annular graft segments 120. For example, endo-annular graft segments 120 may include portions of inner graft elements 108 and outer graft elements 112 located between adjacent annular stent elements 104. As will be discussed further, the properties of endo-annular graft segments 120, including the length of segments 120, may be manipulated to provide desired properties of stent graft 100.
[0087] In various embodiments, the first annular stent element 106a includes a first vertex 120a, and the second annular stent element 106b includes a second vertex 120b. The first vertex 120a and the second vertex 120b can be adjacent to each other. For example, the first annular stent element 106a and the second annular stent element 106b can be oriented relative to each other so that the first vertex 120a and the second vertex 120b are in a common plane 190 perpendicular to the longitudinal axis 192. In other words, the first vertex 120a and the second vertex 120b are in phase with each other. In other embodiments, the first vertex 120a and the second vertex 120b are not in a common plane perpendicular to the longitudinal axis 192 (i.e., the vertices 120a and 120b are out of phase, or otherwise not coplanar with each other). Although described with reference to specific embodiments, any orientation of the annular stent element 104, including multiple different orientations with the same medical device (i.e., stent graft), is within the scope of the present disclosure.
[0088] Stent graft 100 can be delivered to and deployed within a patient's treatment area. Figure 2A and Figure 2B , the stent graft 100 can be prepared and installed to a catheter assembly 260, which includes a catheter tube 262 having a continuous lumen 264. A covering 266 can coaxially surround a balloon 268, which is coupled to the catheter tube 262 and the continuous lumen 264 at or near the distal end of the catheter tube 262. Attachment of the covering 266 to the catheter tube 262 can be achieved in a variety of ways, including adhering the proximal and distal ends of the covering 266 to the catheter tube 262 using an adhesive such as a cyanoacrylate adhesive. In addition, polymeric tapes and / or films can be used to secure the proximal and distal ends of the covering 266 to the catheter tube 262.
[0089] The balloon 268 may include, for example, a generally tubular shaped balloon that is capable of being inflated within the patient's vasculature when pressurized. For example, a biocompatible fluid such as water or saline solution may be introduced into the catheter tube 262, through the continuous lumen 264 and through an inflation port (not shown) in the catheter tube 262 located inside the balloon 268, and pressurize the balloon 268. As the pressure to the balloon 268 increases, the diameter of the balloon 268 also increases.
[0090] Balloon 268 may include, for example, a non-compliant, substantially non-elastic balloon. In such embodiments, balloon 268 may include a material that is configured to allow balloon 268 to expand to a selected diameter when fully pressurized and remain at or near the selected diameter under further pressurization until a burst pressure is reached, for example, nylon, polyethylene, polyethylene terephthalate (PET), polycaprolactam, polyester, polyether, polyamide, polyurethane, polyimide, ABS copolymer, polyester / polyether block copolymer, ionomer resin, liquid crystal polymer, and rigid rod polymer.
[0091] In various embodiments, balloon 268 may include a compliant, relatively elastic balloon. In such embodiments, balloon 268 may include a material configured to allow a continuous increase in the diameter of balloon 268 as pressure to balloon 268 increases, such as, for example, polyurethane, latex, and elastomeric silicone polymers such as polysiloxane. When the limit of expansion is reached, balloon 268 may rupture.
[0092] In yet other embodiments, balloon 268 comprises a semi-compliant balloon. In such embodiments, balloon 268 exhibits a combination of compliant and non-compliant properties. Although described in conjunction with compliant and non-compliant embodiments, any material or configuration that allows balloon 268 to inflate within the patient's body in a predictable manner, including a combination of compliant and non-compliant properties, is within the scope of the present disclosure.
[0093] Reference Figure 3 In various embodiments, the balloon 268 can include a plurality of pleats 370. The pleats 370 can include, for example, folds or inflections in the material of the balloon 268 that generally extend along at least a portion of the longitudinal axis 192. In such embodiments, the balloon 268 includes a generally tubular shape having one or more pleats 370.
[0094] In various embodiments, the balloon 268 can be coaxially surrounded by the covering 266. The covering 266 can include an inner surface that can substantially conform to the outer surface of the balloon 268 such that the balloon 268 and the covering 266 both include substantially the same shape, including when the balloon 268 is deflated. However, in other embodiments, the covering 266 can include a different shape or configuration than the balloon 268.
[0095] In various embodiments, the covering 266 may include a plurality of pleats 372. Similar to the balloon 268, the pleats 372 may include, for example, folds or inflection points in the material of the covering 266 that extend generally along at least a portion of the longitudinal axis. In such an embodiment, the covering 266 includes a generally tubular shape having two or more pleats 372. In various embodiments, the covering 266 includes the same number of pleats 372 as the balloon 268. In various embodiments, along at least one section or the entire working length of the balloon covering 266, the inner surface of the balloon covering 266 intersects with the outer surface of the balloon 268 in both a pleated collapsed configuration and an unpleated inflated configuration. In other words and as Figure 3 As shown, the pleated portions of the covering 266 substantially correspond in configuration to the corresponding pleated portions of the balloon 268, and the unpleated portions of the covering 266 substantially correspond in configuration to the corresponding unpleated portions of the balloon 268.
[0096] The pleats 370 and 372 can be simultaneously formed in the covering 266 and the balloon 268. For example, the balloon 268 can be coaxially surrounded by the covering 266, and the pleats 370 and 372 can then be formed in both the balloon 268 and the covering 266, respectively.
[0097] In other embodiments, pleats 372 may be formed in the covering 266 after pleats 370 are formed in the balloon 268. For example, a pre-pleated balloon 268 may be coaxially surrounded by the covering 266. In such embodiments, both the covering 266 and the pre-pleated balloon 268 may be inflated together to an operating pressure, after which the covering 266 and the balloon 268 are subjected to a mechanical pleat forming process that may, for example, form the same number and configuration of pleats in the covering 266 as in the pre-pleated balloon 268. While pleats 372 are being formed in the covering 266, both the covering 266 and the balloon 268 may be deflated and compacted for delivery into a patient. Although described in specific embodiments, any manner of forming pleats in the covering 266 is within the scope of the present disclosure.
[0098] In still other embodiments, the balloon 268 may include a plurality of pleats 370, and the covering 266 may not include pleats 372. In such embodiments, the pleats 370 may be formed in the balloon 268, and then the covering 266 may be coaxially placed around the outer surface of the balloon 268. Although described with reference to specific examples (i.e., both the balloon 268 and the covering 266 include pleats, or only the balloon 268 or the covering 266 include pleats), any configuration in which the balloon 268 and / or the covering 266 include a plurality of pleats is within the scope of the present disclosure.
[0099] The covering 266 may include, for example, a polymer, such as an expanded fluoropolymer, such as expanded polytetrafluoroethylene (ePTFE), modified (e.g., dense) ePTFE, and expanded copolymers of PTFE. In various embodiments, the polymer may include a node and fibril microstructure. In various embodiments, the polymer may be highly fibrillated (i.e., a nonwoven web of fused fibrils). Although described in conjunction with specific polymers, any material or configuration that allows the covering 266 to expand in a predictable manner within the patient's body is within the scope of the present disclosure.
[0100] In various embodiments, the covering 266 may include multiple layers of polymeric material. For example, the covering 266 may include a polymeric material that is continuously wrapped around a substrate or mandrel to form a generally tubular member. In various embodiments, the covering 266 may be configured with a circumferentially, helically, or axially oriented polymeric material. In such embodiments, the polymeric material may be wrapped substantially perpendicular to the longitudinal axis of the mandrel or substrate, i.e., circumferentially. In other embodiments, the material may be wrapped at an angle between greater than 0 degrees and less than 90 degrees relative to the longitudinal axis of the mandrel or substrate, i.e., helically. In yet other embodiments, the polymeric material may be wrapped substantially parallel to the longitudinal axis of the mandrel or substrate, i.e., axially (or longitudinally) wrapped.
[0101] Reference Figure 2B , the covering 266 may, for example, have a length 282 that is greater than the length 280 of the balloon 268. In various embodiments, the covering 266 is placed around the balloon 268 such that the first covering end 270 and the second covering end 272 extend beyond the first balloon end 274 and the second balloon end 276. In such embodiments, a section 284 of the material of the covering 266 positioned at the first covering end 270 or the second covering end 272 may be compressed (i.e., axially compressed) along the longitudinal axis 192. For example, referring to Figure 4A and Figure 4B , a section 284 of the material of the cover 266 may be axially compressed (eg, constricted) at the first cover end 270 , and a section 286 may be axially compressed at the second cover end 272 .
[0102] like Figure 4A and Figure 4B As shown, segment 284 and / or segment 286 are aligned with first balloon shoulder 290 and / or second balloon shoulder 292. In other embodiments, segment 284 and / or 286 are aligned with different portions of balloon 268. Figure 4A and Figure 4B In the embodiment, the first balloon shoulder 290 and / or the second balloon shoulder 292 are tapered shoulders. Although described with reference to specific embodiments, any shape of balloon shoulder is within the scope of the present disclosure.
[0103] The segment 284 can be positioned, for example, so that it surrounds at least a portion of the first balloon shoulder 290, and the segment 284 can be positioned so that it surrounds at least a portion of the second balloon shoulder 292. Providing additional axial compression (e.g., constriction) material around the balloon shoulders (e.g., balloon shoulders 290 and 292) can increase the thickness and / or density of the covering 266 in the general area of the balloon shoulders. In addition, having the additional axial compression material of the covering 266 on the balloon shoulders allows the balloon 268 to expand during inflation while limiting axial compression of the balloon. For example, without these compression portions, the shoulders of the balloon would inflate before the body of the balloon and cause axial compression of the balloon and the endoprosthesis. But with the axially compressible material, the shoulder of the balloon can expand in a manner that causes less axial compression of the endoprosthesis (e.g., due to the altered angle between the expanded portion of the balloon and the unexpanded or less expanded portion of the balloon) until the pressure within the balloon as a whole is sufficient to more fully expand the cover and the endoprosthesis surrounding the body of the balloon. In addition, the increased thickness and / or density in the general area of the balloon shoulders 290 and 292 can provide additional radial strength to the balloon shoulders to achieve a similar effect.
[0104] As previously described above, balloon 268 may be inflated by providing pressurized fluid into balloon 268 . Figures 5A-5F An example of a covering 266 is shown that limits the expansion of the balloon 268 to a desired inflation profile when the balloon 268 is inflated. The middle portion 200 of the stent graft 100 applies resistance to the expansion of the balloon 268 at the middle portion 20 of the stent graft 100 and at or near the free ends 196, 198. The covering 266 also applies resistance to the expansion of the balloon to reduce the difference in the expansion rate of the balloon 268 at the free ends 196, 198 of the stent graft 100 relative to the expansion rate of the balloon 268 at the middle portion 200 of the stent graft 100, so as to prevent the stent graft 100 from expanding when the balloon 268 moves from its undeployed state ( Figure 5A ) expands to its expanded state ( Fig. 5F ) to reduce longitudinal compression of the stent graft 100. In some embodiments, the cover 266 is used to balance the expansion rate of the balloon 268 at the middle portion 200 of the stent with the expansion rate of the balloon at or near the free ends 196, 198 (e.g., at or near the shoulders).
[0105] For reference, the term "expansion rate" is meant to include changes in diameter as a function of pressure, changes in diameter over time, or both. For example, balancing the expansion rates of the balloon at the middle portion and the free end includes the balloon reaching substantially the same diameter at the middle portion and the free end at a given pressure (either at substantially the same time, or with some delay between reaching that diameter at the middle portion and reaching that diameter at the free end). Thus, in some embodiments, a reduction in the difference in expansion rate includes, for example, a reduction in the difference in pressure required to reach substantially the same expanded diameter at the middle portion and the free end.
[0106] For example, in some embodiments, axial compression sections 284 and / or 286 are configured to provide additional resistance to expansion of balloon shoulders 290 and 292, thereby causing middle portion 294 of balloon 268 to inflate more easily than it would without such sections 284 and 286, which limits expansion of the balloon shoulders to more closely match expansion of middle portion 294 of balloon 268. Axial compression sections 284 and / or 286 may also substantially impede inflation of balloon shoulders 290 and / or 292. In various embodiments, this has the effect of controlling the extent of balloon inflation in these regions, which in turn controls the expansion profile of balloon 268 and / or stent graft 100.
[0107] In various embodiments, the expansion of balloon 268 can be controlled by covered segments 284 and / or 286 in a manner that can reduce undesirable expansion characteristics of stent graft 100. For example, covered segments 284 and / or 286 can reduce the extent to which stent graft 100 shortens during expansion. In particular, segments 284 and / or 286 can be configured to force the balloon to form a specific inflation profile in which the axial force generated by inflating the shoulder of the balloon is significantly reduced, for example, due to a reduced angle between the shoulder portion of the balloon and the middle portion of the balloon or stent graft. In addition, covered segments 284 and / or 286 can reduce or prevent stacking of stent graft 100 (e.g., reducing the spacing between annular stent elements 106 during expansion).
[0108] Reference Figure 2A and Figure 2B, after the balloon 268 is surrounded by the covering 266, the stent graft 100 can be loaded onto the balloon 268 and the covering 266. For example, the stent graft 100 can be positioned concentrically around the covering 266 and a portion of the balloon 26. In various embodiments, once the stent graft 100 is properly positioned around the balloon 268 and the covering 266, the stent graft 100 is radially compressed to the undeployed diameter 242. For example, during implantation in a treatment area, the stent graft 100 can be compacted to the undeployed diameter 242 to reduce the profile of the stent graft 100. In addition, the stent graft 100 can be compacted to the balloon 268 and the covering 266 to resist movement of the stent graft on the balloon 268 prior to deployment.
[0109] In various embodiments, after compaction, stent graft 100 may embed itself into covering 266. For example, stent graft 100 may exhibit improved stent retention by embedding itself into covering 266. Such improved stent retention may, for example, help maintain proper positioning of stent graft 100 relative to covering 266 and / or balloon 268 during deployment to a treatment area of a patient.
[0110] Another way to limit any reduction in the length of the endoprosthesis (e.g., as measured between one free end 196 and an opposite free end 198) between its compressed and expanded configurations is by changing the position and / or orientation of the annular stent elements 104 of the stent component 102. In particular, in some embodiments, the position and / or orientation of one or more annular stent elements 104 of the stent component 102 can be changed prior to compacting the stent graft 100. For example, the distance between two or more adjacent annular stent elements 104 can be reduced prior to compacting the stent graft 100. For more specific examples, one or more annular stent elements 104 can be moved so that they are less than about 1 mm away from each other, or even so that they are in contact with each other (i.e., spaced 0 mm apart from each other).
[0111] In other embodiments, the position and / or orientation of the annular stent elements 104 may be changed after compacting the stent graft 100. For example and with reference to Figure 2A, the length of the stent graft 100 can be changed by reducing the longitudinal spacing between two or more annular stent elements 104. Reducing the longitudinal spacing between adjacent annular stent elements 104 can, for example, form a stored longitudinal length that is recovered when the stent elements 104 are expanded to their deployed state. For example, the stored longitudinal length can be defined as the length or segment of graft material of the axially compressed intra-annular graft segment 120 between adjacent annular stent elements 104 that is recovered (i.e., axially expanded) when the stent graft 100 is expanded and deployed. The "undeployed length" of the stent graft 100 generally refers to the stent graft 100 in the compressed state prior to delivery, and the "deployed length" of the stent graft 100 generally refers to the stent graft 100 in the expanded state. In some embodiments, changing the spacing of the annular stent elements 104 forms a new length, which can be referred to as the undeployed length (e.g., Figure 2A Length 240).
[0112] In other words, reducing the spacing between adjacent stent elements 104 can axially compress or constrict the endograft segment 120. By forming the stored length via axial compression, the outer diameter of the stent graft 100 is not increased. By not increasing the diameter of the device while forming the stored length, the cross-section of the device remains minimal and thus does not adversely affect the delivery of the stent graft through the vasculature. At the same time, the recovery of the stored length increases the ability of the stent graft to reduce or offset any length loss due to, for example, axial compressive forces from inflating a balloon.
[0113] When the stent graft 100 is delivered to the treatment area of the patient, the stent graft 100 can be deployed. In various embodiments, the stent graft 100 is deployed by inflating the balloon 268 to the desired diameter, thereby increasing the diameter of the stent graft 100 from the undeployed diameter 242 to the deployed diameter 146. This process further increases the length of the stent graft from the undeployed length 240 to the deployed length 148. After the balloon 268 is sufficiently inflated to achieve the deployed diameter 146, the balloon 268 can be deflated to allow the catheter assembly 260 to be removed from the patient's body.
[0114] The deployed length 148 can be, for example, less than the undeployed length 240. For example, the deployed length 148 can be about 60% to about 95% of the undeployed length 240, and further about 80% to about 90% of the undeployed length 240. Testing has shown that certain embodiments have achieved a deployed length 148 greater than 99% of the undeployed length, thereby demonstrating a shortened length of less than 1%. The ability of a stent graft to achieve a higher percentage of its undeployed length is also referred to herein as longitudinal efficiency.
[0115] Expanding the stent graft 100 from the undeployed configuration to the deployed configuration may also, for example, increase the internal angle of one or more wire frames 106 of the ring-shaped stent elements 104. For example, when the stent graft 100 is in the deployed configuration, the internal angle 188 of the wire frames 106 of the ring-shaped stent elements 104 may be between about 70 degrees and 110 degrees, and further between about 80 degrees and 100 degrees.
[0116] Example 1 – Bend Radius
[0117] Various stent grafts according to the present disclosure are tested to evaluate their flexibility in the deployed configuration. Specifically, the stent grafts are tested to determine the bending radius to which the stent graft can accommodate without kinking and can recover its original size and shape after testing. Kinking occurs at the point where the stent graft has a diameter reduction of greater than 50%, or when it fails to recover its original size and shape after testing.
[0118] The stent grafts were tested according to Method A of Chapter D.5.3.6 of ISO 25539-2 (2009), except that: 1) the test was not conducted in a tube with the minimum nominal indicated vessel diameter or the maximum indicated vessel diameter, and 2) the overlap condition test was not conducted. The stent grafts included stainless steel annular stent elements spaced approximately 0.5 mm to 1.5 mm from each other. The stent was approximately 59 mm long. The inner and outer graft elements included ePTFE, and the stent graft was mounted on a nylon balloon surrounded by an ePTFE cover having constricted proximal and distal ends. The results of the bend radius testing are summarized in Table 1 below.
[0119] Table 1
[0120]
[0121] Example 2 – Radial Strength
[0122] Various stent grafts according to the present disclosure were tested to evaluate their radial strength in a deployed configuration. Specifically, the stent grafts were tested to determine the radial compression pressure at which the stent grafts would become irrecoverably deformed.
[0123] Stent grafts were tested as specified in ISO 25539-2:2009, Chapter D.5.3.4, except that: 1) pressures were expressed in pounds per square inch, and 2) testing was conducted until a 50% reduction in nominal device diameter was achieved.
[0124] The stent graft comprised stainless steel annular stent elements spaced approximately 0.5 mm to 1.5 mm apart from one another. The stent was approximately 59 mm long. The inner and outer graft elements comprised ePTFE, and the stent graft was mounted on a nylon balloon surrounded by an ePTFE cover having constricted proximal and distal ends. The results of the radial strength testing are summarized below in Table 2.
[0125] Table 2
[0126]
[0127]
[0128] Although specific embodiments of the present invention have been illustrated and described herein, the present invention should not be limited to such illustration and description. It should be understood that changes and modifications may be incorporated and embodied as part of the present invention within the scope of the appended claims.
[0129] Many features and advantages have been described in the foregoing description, including various alternatives together with details of the structure and function of the apparatus and / or method. The present disclosure is intended to be exemplary only, and is therefore not intended to be exhaustive. It will be apparent to those skilled in the art that various modifications may be made to the entirety indicated by the broad, general meaning of the terms expressing the appended claims, particularly in terms of the structure, materials, elements, components, shapes, sizes, and arrangement of parts including combinations within the principles of the invention. As long as these various modifications do not depart from the spirit and scope of the appended claims, they are intended to be covered by the claims.
Claims
1. A component comprising: A catheter assembly, the catheter assembly comprising: a balloon having a first balloon end, a second balloon end, and an intermediate balloon portion interposed therebetween, and a covering concentrically surrounding at least a portion of the balloon; and an implantable medical device coupled to the catheter assembly, the implantable medical device defining a first end, a second end, and an intermediate portion between the first end and the second end, the implantable medical device being expandable between an undeployed state having an undeployed diameter and a deployed state having an expanded diameter, wherein both the implantable medical device and the covering apply resistance to expansion of the balloon at the middle balloon portion to reduce the difference in diameter of the balloon at the first balloon end and the second balloon end relative to the diameter of the balloon at the middle balloon portion during expansion, and wherein the covering is unpleated when the medical device is in the undeployed state.
2. The assembly according to claim 1, characterized in that The covering is configured such that an expansion rate of the middle portion of the balloon is closer to an expansion rate of the first balloon end portion and the second balloon end portion.
3. The assembly according to claim 1, characterized in that The implantable medical device is a stent graft.
4. The assembly according to claim 1, characterized in that The balloon includes at least one of a non-compliant material or a semi-compliant material.
5. The assembly according to claim 1, characterized in that The balloon comprises a compliant material.
6. The assembly according to claim 1, characterized in that The balloon includes a plurality of folds in the undeployed state.
7. The assembly according to claim 1, characterized in that The deployed diameter of the implantable medical device is substantially equal at the first end, the second end, and the intermediate portion in the deployed state.
8. The assembly according to claim 1, characterized in that The covering is configured to reduce longitudinal compression of the implantable medical device during expansion.
9. The assembly according to claim 8, characterized in that The covering is configured to reduce an angle formed between the first balloon end and the middle balloon portion during expansion.
10. The assembly according to claim 8, characterized in that The implantable medical device includes a stent having a plurality of annular stent elements, and the covering is configured to reduce stacking of the annular stent elements.
11. The assembly according to claim 10, characterized in that The deployed length of the stent exhibits less than 1% shortening compared to the undeployed length of the stent.
12. The assembly of claim 1, wherein: The length of the implantable medical device in the deployed state is at least 85% of the length of the implantable medical device in the undeployed state.
13. A component comprising: A catheter assembly, the catheter assembly comprising: a balloon having a first balloon end, a second balloon end, and an intermediate balloon portion interposed therebetween, and a covering concentrically surrounding at least a portion of the balloon; and a stent graft coupled to the catheter assembly, the stent graft defining a first end, a second end, and an intermediate portion between the first end and the second end, the stent graft being expandable between an undeployed state having an undeployed length and a deployed state having a deployed length, the stent graft comprising: Internal graft elements, External graft components, and a stent positioned between the inner graft element and the outer graft element, wherein the covering is constructed to reduce the difference in diameter of the balloon at the first balloon end and the second balloon end relative to the diameter of the balloon at the middle balloon portion during expansion by applying resistance to expansion at the middle balloon portion during expansion so as to reduce shortening of the stent graft such that the deployed length of the stent graft exhibits a shortening of less than 1% compared to the undeployed length of the stent graft.
14. The assembly according to claim 13, characterized in that The deployed diameter of the stent graft in the deployed state is substantially equal at the first end, the second end, and the middle portion.
15. The assembly of claim 13, wherein: The expanded diameter is at least 85% of the undeployed diameter.
16. The assembly of claim 13, wherein: The inner graft element and the outer graft element include ePTFE.
17. The assembly of claim 13, wherein: The stent includes a plurality of annular stent elements, and the cover is configured to reduce stacking of the annular stent elements.
18. The assembly of claim 13, wherein: When the stent graft is in the undeployed state, the covering is unpleated.
19. The assembly of claim 13, wherein: The balloon includes a plurality of folds in the undeployed state.
20. The assembly of claim 13, wherein: The covering is configured such that an expansion rate of the middle portion of the balloon is closer to an expansion rate of the first balloon end portion and the second balloon end portion.
